Total planned funding: $135,098,224
Allocations
Countries/Regions
Ukraine | $135,098,224 |
Organizational Types
NGO | $32,736,049 |
Unknown | $31,955,079 |
Private Contractor | $29,276,788 |
Own Agency | $14,566,394 |
Multi-lateral Agency | $11,288,586 |
University | $6,589,234 |
Other USG Agency | $4,614,094 |
Implementing Agency | $4,072,000 |
Program Areas
Governance and Systems | $54,894,284 |
Treatment | $25,668,121 |
Testing | $22,891,185 |
Prevention | $14,369,432 |
Management and Operations | $9,358,221 |
Care | $7,504,281 |
Budget Codes
OHSS: Health Systems Strengthening | $28,906,688 |
HVCT: Testing: HIV Testing and Counseling | $22,891,185 |
HVSI: Strategic Information | $15,117,249 |
HTXS: Treatment: Adult Treatment | $14,262,831 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $10,870,347 |
HVMS: Management and Operations | $9,358,221 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,001,751 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,152,649 |
HVTB: Care: TB/HIV | $4,600,861 |
HMBL: Biomedical Prevention: Blood Safety | $2,142,932 |
HBHC: Care: Adult Care and Support | $1,640,341 |
HKID: Care: Orphans and Vulnerable Children | $1,263,079 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $72,100 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$20,504,936
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
USG Aggregated Agencies:
$10,541,744
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions